Franca Formelli - Concepedia

Author

Franca Formelli

Fondazione IRCCS Istituto Nazionale dei Tumori

Also Known As

F FORMELLI, F Formelli, F. FORMELLI, F. Formelli, FRANCA FORMELLI, Franca Formelli

175

Publications

7.6K

Citations

H-Index

Concepts

All Affiliations

Fondazione IRCCS Istituto Nazionale dei Tumori European Institute of Oncology University of Milan Tumori Foundation Istituti di Ricovero e Cura a Carattere Scientifico

About

Franca Formelli is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in medicine, pharmacology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	61	4.1K
2	Health Sciences	6	6	415
3	Natural Sciences	2	2	221
4	Biochemistry	2	2	63
5	Allergy	1	1	18

Franca Formelli

Publications

7.1K

Citations

H-Index

Page 1

	Year	Citations
Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells Valentina Zuco, Rosanna Supino, Sabina Carla Righetti, Cancer Letters Tumor BiologyOncogenic AgentMedicineSelective CytotoxicityBetulinic Acid	2002	521
Randomized Trial of Fenretinide to Prevent Second Breast Malignancy in Women With Early Breast Cancer Umberto Veronesi, G. De Palo, Ettore Marubini, JNCI Journal of the National Cancer Institute	1999	421
In Vivo Eradication of Human BCR/ABL-Positive Leukemia Cells With an ABL Kinase Inhibitor Philipp le Coutre, Luca Mologni, Loredana Cleris, JNCI Journal of the National Cancer Institute	1999	377
<i>In vitro</i> and <i>In vivo</i> Activity of SKI-606, a Novel Src-Abl Inhibitor, against Imatinib-Resistant Bcr-Abl+ Neoplastic Cells Miriam Puttini, Addolorata Maria Luce Coluccia, Frank Boschelli, Cancer Research Hematological MalignancyCell SignalingSki-606 ActivityMedicineImmunology	2006	368
N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid. Domenico Delia, Antonella Aiello, Luciano Lombardi, PubMed Chemoprevention StrategyRetinamide Induces ApoptosisRetinoic Acid ReceptorApoptosisCell Death	1993	248
Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancer Umberto Veronesi, Luigi Mariani, Andrea DeCensi, Annals of Oncology Breast OncologyOncologySecond Breast CancerMedicineBreast Cancer	2006	214
Five-year administration of fenretinide: pharmacokinetics and effects on plasma retinol concentrations. Franca Formelli, Mario Clerici, Tiziana Campa, Journal of Clinical Oncology	1993	201
Synthesis and antitumor properties of new glycosides of daunomycinone and adriamycinone Federico Arcamone, Sergio Penco, Aristide Vigevani, Journal of Medicinal Chemistry Beta AnomersMedicinal ChemistryAntitumor PropertiesBioorganic ChemistryPharmaceutical Chemistry	1975	193
Phase I trial and pharmacokinetics of fenretinide in children with neuroblastoma. Alberto Garaventa, Roberto Luksch, M. S. Lo Piccolo, PubMed	2003	189
Regulation of apoptosis induced by the retinoid N-(4-hydroxyphenyl) retinamide and effect of deregulated bcl-2 D Delia, Antonella Aiello, Franca Formelli, Blood	1995	146

Page 1